What is Phase Focus?
Phase Focus Limited is at the forefront of live cell imaging technology, renowned for its product Livecyte, which provides automated cell tracking and analysis. Leveraging patented quantitative phase imaging, the company enables high-content live-cell assays crucial for characterizing cell growth, morphology, and motility. Its solutions are vital for researchers in fields such as oncology and stem cell imaging, addressing complex biological questions within the life sciences sector. Phase Focus's commitment to innovation has been recognized through multiple industry awards.
How much funding has Phase Focus raised?
Phase Focus has raised a total of $6.8M across 3 funding rounds:
Unspecified
$1.2M
Unspecified
$571K
Unspecified
$5M
Unspecified (2008): $1.2M with participation from Fusion IP and Spirit Capital Partners
Unspecified (2009): $571K led by Maven Capital Partners UK, South Yorkshire Investment fund, and Yorkshire association of business angels
Unspecified (2012): $5M supported by Ombu Group
Key Investors in Phase Focus
Ombu Group
Ombu Group is an investment firm specializing in advanced environmental technology companies, providing substantial strategic and operational support to foster sustainable business growth.
Fusion IP
Fusion IP is an entity involved in the investment landscape, contributing to the financial backing of technology-focused companies.
Spirit Capital Partners
Spirit Capital Partners is a private equity fund manager focused on creating capital value in the UK SME segment through active asset management and new investments.
What's next for Phase Focus?
With the recent major strategic investment, Phase Focus is poised for accelerated expansion and further development of its cutting-edge live cell imaging platforms. This capital infusion is expected to bolster its research and development efforts, enhance its market penetration, and potentially drive new product innovations. The company's focus on advanced quantitative phase imaging positions it for continued leadership in high-content live-cell analysis, catering to the evolving needs of the global life sciences research community.
See full Phase Focus company page
